Geovax Labs Inc (STU:E8LA)
€ 93.53 (0%) Market Cap: 4.28 Mil Enterprise Value: 3.51 Mil PE Ratio: 0 PB Ratio: 5.35 GF Score: 22/100

GeoVax Labs Inc at Biotech Showcase Transcript

Jan 13, 2026 / 10:30PM GMT
Release Date Price: €93.53
Unidentified Particpant

Our next presenting company is GeoVax Labs from Smyrna, Georgia.

GeoVax is focused on infectious disease, oncology, and vaccines.

Presenting for GeoVax Labs is [old friend], David Dodd. David, thank you.

David Dodd
GeoVax Labs Inc - Chairman of the Board, President, Chief Executive Officer

Thank you. Excuse me. Thank you. Thank you for your interest and your attention.

Oh. It's a pleasure to be here. Welcome to San Francisco. We're a Nasdaq company; listed on the Nasdaq. GOVX is our symbol.

I'm going to go through this. If we have time, I'll take questions. If we don't have time, if you have questions, I can address those probably outside.

This is -- I'm not going to go through every slide. If you're interested in these slides (inaudible) create any type of interest and motivation in you, let me know and I'll send you the presentation. We'll do it that way. We'll probably have it posted on the website.

But this is our investment thesis. Basically, we have multiple clinical-stage programs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot